Prevention of COVID-19 in pregnant women, eventual use of new vaccines

Simple item page
dc.contributor.authorCésar Cuadra-Sánchez
dc.contributor.authorAlexandra Rivero
dc.contributor.authorCarlos Cabrera
dc.contributor.authorPedro Faneite
dc.contributor.authorPaulino Vigil‐De Gracia
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:02:39Z
dc.date.available2026-03-22T16:02:39Z
dc.date.issued2021
dc.descriptionCitaciones: 2
dc.description.abstractPregnant women who have COVID-19 have an increased risk of hospitalization and death; however, there are many restrictions for the application of COVID-19 vaccines on pregnant patients, mainly because there is no confirmation of the safety of their use during pregnancy. None of the vaccines approved to date are based on live attenuated SARS-CoV-2, so the possibility of generating an infection in the fetus is nonexistent.
dc.identifier.doi10.47307/gmc.2021.129.2.15
dc.identifier.urihttps://doi.org/10.47307/gmc.2021.129.2.15
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/55909
dc.language.isoen
dc.relation.ispartofGaceta Médica de Caracas
dc.sourceUniversidad de Los Andes
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectMedicine
dc.subjectPregnancy
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subject2019-20 coronavirus outbreak
dc.subjectFetus
dc.subjectObstetrics
dc.subjectVirology
dc.titlePrevention of COVID-19 in pregnant women, eventual use of new vaccines
dc.typearticle

Files

Collections

Artículo Científico Publicado